Reviva Pharmaceuticals RVPH
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 0.73 | 17 | -24.5 | -3 | -16.19 | 24 |
| 2025Q4 | 5.58 | 9 | -51.04 | -3 | -22.26 | 16 |
| 2025Q3 | 7.37 | 5 | -4 | -30.89 | 14 | |
| 2025Q2 | 7.62 | 0 | -6 | -64.71 | 12 | |
| 2025Q1 | 19.08 | -4 | -6 | -56.98 | 7 | |
| 2024Q4 | 36.2 | 1 | -6 | -54.11 | 16 | |
| 2024Q3 | 28.8 | -10 | -8 | -106.69 | 8 | |
| 2024Q2 | 25.6 | -6 | -8 | -72.95 | 8 | |
| 2024Q1 | 75.6 | -1 | -7 | -39.97 | 13 | |
| 2023Q4 | 103 | 6 | -9 | -64.32 | 24 | |
| 2023Q3 | 97.6 | -9 | -11 | -127.42 | 5 | |
| 2023Q2 | 117.2 | 2 | -329.3 | -12 | -98.56 | 12 |
| 2023Q1 | 83.8 | 6 | -72.96 | -7 | -41.49 | 13 |
| 2022Q4 | 85 | 12 | -49.69 | -8 | -37.79 | 19 |
| 2022Q3 | 31.8 | 20 | -19.3 | -4 | -15.73 | 24 |
| 2022Q2 | 22 | 16 | -28.55 | -5 | -23.27 | 21 |
| 2022Q1 | 49.2 | 21 | -29.43 | -7 | -25.99 | 25 |
| 2021Q4 | 57.8 | 29 | -12.09 | -4 | -11.29 | 31 |
| 2021Q3 | 81.4 | 32 | -6.82 | -2 | -6.47 | 34 |
| 2021Q2 | 97.2 | 35 | -8.24 | -2 | -7.45 | 37 |